Standard BioTools (FLB) Ownership - Who Owns Standard BioTools?
Standard BioTools (FLB) Ownership Overview
- 49.50% Insiders
- 5.37% Mutual Funds
- 3.34% Other Institutional Investors
- 4.87% ETFs
- 36.92% Public Companies and Individual Investors
The ownership structure of Standard BioTools (DE:FLB) stock is a mix of institutional, retail, and individual investors. Approximately 13.58% of the company’s stock is owned by Institutional Investors, 49.50% is owned by Insiders, and 36.92% is owned by Public Companies and Individual Investors.
The ownership structure of Standard BioTools (DE:FLB) stock is a mix of institutional, retail, and individual investors. Approximately 13.58% of the company’s stock is owned by Institutional Investors, 49.50% is owned by Insiders, and 36.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 03, 2025 | Casdin Partners Master Fund, L.p. | $501,500 | |
| Nov 25, 2025 | Casdin Partners Master Fund, L.p. | $10,029,500 | |
| Nov 19, 2025 | Casdin Partners Master Fund, L.p. | $1,371,250 | |
| Nov 16, 2025 | Casdin Partners Master Fund, L.p. | $1,122,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | €31,496 | |
| Dec 31, 2025 | Primecap Management Co | €196,318 | |
| Dec 31, 2025 | Royce & Associates Llc | €3,693,477 | |
| Dec 31, 2025 | Ark Investment Management Llc | €3,925,331 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Eli Casdin | 91,837,025 | Insider | 23.27% | 56,479,770 |
| Casdin Partners Master Fund, L.p. | 91,684,918 | Insider | 23.23% | 56,386,225 |
| Andreas Halvorsen | 58,651,170 | Institution | 14.86% | 36,070,470 |
| Vanguard | 12,882,139 | Institution | 3.26% | 7,922,515 |
| Vanguard Index Funds | 11,854,127 | Institution | 3.00% | 7,290,288 |
| BlackRock, Inc. | 8,254,443 | Institution | 2.09% | 5,076,482 |
| Michael Egholm | 6,137,704 | Insider | 1.55% | 3,774,688 |
| Chuck Royce | 4,525,333 | Institution | 1.15% | 2,783,080 |
| Ishares | 3,785,400 | Institution | 0.96% | 2,328,021 |
| Cathie Wood | 3,066,665 | Institution | 0.78% | 1,885,999 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 11,854,127 | Institution | 3.00% | 7,290,288 |
| Fidelity Concord Street Trust | 2,746,373 | Institution | 0.70% | 1,689,019 |
| Neuberger Berman Equity Funds | 2,104,024 | Institution | 0.53% | 1,293,975 |
| Royce Fund | 1,247,908 | Institution | 0.32% | 767,463 |
| Vanguard World Fund | 682,905 | Institution | 0.17% | 419,987 |
| Morgan Stanley Institutional Fund Inc | 660,511 | Institution | 0.17% | 406,214 |
| Royce Capital Fund | 406,372 | Institution | 0.10% | 249,919 |
| Vanguard Institutional Index Funds | 158,162 | Institution | 0.04% | 97,270 |
| Schwab Capital Trust | 150,000 | Institution | 0.04% | 92,250 |
| Vanguard Valley Forge Funds | 140,345 | Institution | 0.04% | 86,312 |
FAQ
Who Owns Standard BioTools (DE:FLB)?
According to the latest TipRanks data, approximately 13.58% of the company's stock is held by institutional investors, 49.50% is held by insiders, and 36.92% is held by public companies and individual investors.
What percentage of Standard BioTools (DE:FLB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.58% of Standard BioTools (DE:FLB) stock is held by institutional investors: 5.37% by mutual funds, 4.87% by ETFs and 3.34% by other institutional investors.
What percentage of Standard BioTools (DE:FLB) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.92% of Standard BioTools (DE:FLB) stock is held by public companies and individual investors.
Who owns the most shares of Standard BioTools (DE:FLB)?
Eli Casdin owns the most shares of Standard BioTools (DE:FLB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
